D-1426-2012 Class III Terminated
FDA drug recall D-1426-2012 was initiated by Fougera Pharmaceuticals, Inc. on Jun 7, 2012 and is designated Class III. Reason for recall: Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product. The recall status is terminated (terminated Nov 30, 2015). Affected quantity: 444 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 1, 2012
- Initiation Date
- Jun 7, 2012
- Termination Date
- Nov 30, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 444 bottles
Product description
Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0.
Reason for recall
Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.
Distribution pattern
Nationwide.
Code information
Lot #: 418N, Exp 06/13
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1426-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026